Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + propofol versus ketamine + midazolam for pediatric dental sedation
IRCT20090506001882N10Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketamine, propofol and midazolam in anxiety disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Success of dental treatment according to Houpt Scale. Started Apr 2021; status: completed.
02
Drugs
ketaminepropofolmidazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20090506001882N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090506001882N10.